Status:
COMPLETED
A Study of Patients With HER2-Positive Metastatic Breast Cancer
Lead Sponsor:
Genentech, Inc.
Conditions:
Breast Cancer
Eligibility:
All Genders
Brief Summary
This is a prospective observational cohort study designed to describe effectiveness and safety (treatment outcomes and clinically significant cardiac adverse events, respectively) in patients with HER...
Eligibility Criteria
Inclusion
- Signed Informed Consent document (unless the IRB has granted a waiver of consent)
- Signed Authorization for the Use and Disclosure of Health Information document
- HER2-positive breast cancer
- Initial diagnosis of metastatic (Stage IV) breast cancer within 6 months prior to enrollment
- Availability of cancer-specific historical data points in the patient's medical records
Exclusion
- There are no exclusion criteria for participation in this trial
Key Trial Info
Start Date :
March 1 2003
Trial Type :
OBSERVATIONAL
End Date :
May 1 2009
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT00105456
Start Date
March 1 2003
End Date
May 1 2009
Last Update
May 6 2010
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.